At a glance
ClinicalIndex Comparison Record- ✓COPD patients with confirmed doctor diagnosis
- ✓COPD patients aged 50-70 years
- ✓COPD patients must be current or ex-smokers
- ✓Asthma patients with confirmed doctor diagnosis
- ✕Age under 18 years
- ✕Currently on oxygen therapy
- ✕COPD patients who are never smokers
- ✕Currently undergoing treatment for acute exacerbations
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Exposure to Secondhand Smoke in Exempted Areas/Outside Areas and Acute Health Effects in Patients With Chronic Lung Disease
In Brief
A clinical study evaluating Exposure to secondhand tobacco smoke for COPD and 2 related conditions. Completed, enrolled 60 participants.
Detailed Summary
Within the TackSHS project (H2020 project grant agreement No 681040), we will conduct a clinical research study, aiming at: i) to measure respiratory health effects when exposed to secondhand smoke (SHS) in patients with asthma and Chronic Obstructive Pulmonary Disease (COPD); ii) to investigate exposure levels to SHS in smoking areas provided by bars, casinos, bingo halls, etc. The study will involve 60 patients (volunteers) in three European countries: Czech Republic, Ireland, and Spain, recruiting 20 patients in each participating country (10 COPD and 10 asthma patients).
Study Details
Timeline
Interventions
The intervention is exposure to secondhand smoke of COPD and asthma patients in outside smoking areas (no specific drugs or devices are tested in this study). Study subjects will be asked to spend at least 15 minutes in the outdoor smoking area, a preferable time of 30-60 mins. During the exposure period (15-60 min) subjects´ respiratory rates will be recorded using RESpeck device, as well as the air quality which will be monitored using AirSpeck device.